Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The Conversation

Pregnant this winter? Here's how to prepare for COVID and get vaccinated

With the days becoming noticeably shorter, winter is on its way in the Southern Hemisphere.

The Conversation

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

300 biotech and pharma CEOs including the head of Pfizer call for a reversal of the abortion pill ban

Pfizer’s Albert Bourla is among the CEOs who signed a letter against suspending mifepristone, citing its impact on the FDA and the biotech industry.

Fortune

Vaccines for cancer could be ready by 2030, according to Moderna chief

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Manchester Evening News

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Independent UK

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Covid jab offered to some babies and children from the age of six months

The vaccine has been approved for use in children age between six months and four years old

Wales Online

3 Low P/E Stocks Gearing Up to Rebound This Year

Recent banking turmoil and rising interest rates have weighed heavily on investors’ sentiment lately. However, weak economic data signaling slowing growth could result in relatively easy monetary policies in the second half of 2023. Given the macroeconomic backdrop, investors could consider adding fundamentally sound low P/E stocks Pfizer (PFE), Chevron…

StockNews.com

Babies and children under five to be offered Covid jab for the first time

The JCVI has advised that clinically vulnerable children aged six months to four years should be offered the vaccincation.

The Independent UK

Covid vaccine to be offered to vulnerable babies and children in UK

Eligible children between six months and four years old will be offered jab from June

The Guardian - UK

Ursula von der Leyen: EU’s ‘general’ nears endgame of turbulent first term

European Commission president is praised for work ethic and response to Covid and Ukraine war, but some see her as aloof

The Guardian - UK

Institute offers booster shots

The Institute of Dermatology is offering a Covid-19 vaccination service using the Gen2-Bivalent Pfizer vaccine at its headquarters on Ratchawithi Road.

Bangkok Post

Covid booster jab rollout to begin for 5 million most vulnerable people

Cases are at their highest level since the start of the year, according to last ever ONS survey

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Covid booster vaccine to be offered to millions in England next week

Care home residents will be first to receive spring top-up jab as infections in England hit 2023 high

Wales Online

Spring Covid booster campaign set to launch next week

Around five million UK residents are eligible for the booster until the end of June

The Independent UK

Spring Covid booster campaign gets under way next week

Millions of people will be sent their initial invitations through the NHS app, where they can also book their appointment.

The New Daily

TGA weighs up RSV vaccine for older Australians

A vaccine for the potentially deadly respiratory syncytial virus (RSV) is being assessed by the TGA for use by people aged over 60.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

I Finally Caught COVID. The Government Made the Experience Even Worse.

Thanks to onerous regulations, life-saving drugs are more expensive and harder to get.

Fortune

Pfizer's chief corporate affairs officer remembers the moment she figured out how to 'break through' to skeptical consumers during COVID

Sally Susman is the author of "Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World."

Bangkok Post

Chinese Foreign Minister Qin Gang assures US business leaders of Beijing's support

China remains committed to a "healthy, stable and constructive" relationship with the US amid still "chilly" bilateral ties, Chinese Foreign Minister Qin Gang told visiting American business leaders on Saturday.

Los Angeles Times

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Kiplinger

Best Defensive Stocks to Buy Now

Investors are concerned about tariffs, inflation, interest rates and economic growth. The best defensive stocks can protect your portfolio against these risks.

The Independent UK

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

Fortune

Moderna faces criticism as it prices COVID vaccine at $130 per dose

Pfizer has said it’s considering a similar price for its vaccine.

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

the Southern Hemisphere

43 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.